Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Families and children news

Show

From To
NIH study shows HIV-exposed children at high risk of language delay

Children exposed to HIV before birth are at risk for language impairments, according to a study by researchers at the National Institutes of Health and other institutions. Moreover, children exposed to HIV before birth may benefit from routine screening for language impairment, even if they don’t have any obvious signs of a language problem, the researchers said.

Published
09 January 2012
From
US National Institutes of Health
Europeans find high prevalence of lipodystrophy in HIV-positive children

A European study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes has found a high prevalence of body fat changes and

Published
05 January 2012
By
Michael Carter
US approval for paediatric use of raltegravir, new chewable tablet also gets the go-ahead

Drug regulatory authorities in the US have approved raltegravir (Isentress) for the treatment of HIV-positive children. In addition, chewable raltegravir tablets in 100mg scored and 25 mg formulations

Published
05 January 2012
By
Michael Carter
ART improves impact of therapeutic feeding in malnourished infants with HIV

HIV-infected malnourished children in urban Malawi who got ART within three weeks of therapeutic feeding were more likely to recover nutritionally (86% compared to 60%, p<0.01) and gained

Published
04 January 2012
By
Carole Leach-Lemens
ETHIOPIA: New PMTCT plan needs men

Ethiopia's new plan to eliminate mother-to-child HIV transmission by 2015 cannot be attained unless men are more meaningfully involved in reproductive health, experts say.

Published
04 January 2012
From
IRIN Plus News
"Tail" Regimens Reduce HIV Resistance After Intrapartum Nevirapine

A single intrapartum dose of nevirapine to prevent HIV transmission to the baby can lead to nevirapine resistance in the mother, but short-term antiretroviral "tail" regimens will substantially cut the risk of that problem, a study from Thailand shows.

Published
03 January 2012
From
Medscape (requires free registration)
New Tests for Latent TB May Be Unreliable in Pregnancy

A new report warns against using interferon gamma release assays (IGRA) to look for tuberculosis in pregnant women.

Published
22 December 2011
From
Medscape (requires free registration)
Updated information about Prezista (darunavir): oral suspension and labeling changes

The Food and Drug Administration approved an oral suspension formulation of Prezista (darunavir). Prezista is now available as a 100 mg/mL oral suspension.

Published
22 December 2011
From
EATG / FDA
Isentress (raltegravir): pediatric dosing recommendations and 2 chewable tablet formulations for pediatric dosing

The Food and Drug Administration approved dosing recommendations for Isentress (raltegravir) for pediatric patients ages 2 to 18 years and weighing at least 10 kg. In addition a 100 mg scored chewable tablet and 25 mg chewable tablet was approved for use in pediatric patients.

Published
22 December 2011
From
EATG / FDA
Nevirapine and cotrimoxazole prophylaxis safe in HIV-exposed, uninfected infants

Use of nevirapine with cotrimoxazole prophylaxis in HIV-exposed uninfected infants (HIV-EU) until six months of age in Zimbabwe and Uganda was safe with no immediate or long-term adverse effects,

Published
15 December 2011
By
Carole Leach-Lemens

Filter by country